COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $379,318 | -15.6% | 101,422 | -3.7% | 0.00% | – |
Q2 2023 | $449,669 | -39.0% | 105,309 | -2.3% | 0.00% | – |
Q1 2023 | $737,270 | -16.0% | 107,788 | -2.7% | 0.00% | – |
Q4 2022 | $877,813 | -15.8% | 110,835 | +2.2% | 0.00% | – |
Q3 2022 | $1,043,000 | +31.5% | 108,488 | -0.9% | 0.00% | – |
Q2 2022 | $793,000 | -43.6% | 109,476 | +0.5% | 0.00% | – |
Q1 2022 | $1,406,000 | -18.3% | 108,924 | +1.0% | 0.00% | – |
Q4 2021 | $1,721,000 | -2.6% | 107,804 | -2.0% | 0.00% | -100.0% |
Q3 2021 | $1,767,000 | +14.7% | 109,987 | -1.3% | 0.00% | – |
Q2 2021 | $1,541,000 | -4.5% | 111,431 | +0.9% | 0.00% | – |
Q1 2021 | $1,614,000 | -24.9% | 110,475 | -10.6% | 0.00% | -100.0% |
Q4 2020 | $2,148,000 | -6.2% | 123,567 | -1.0% | 0.00% | 0.0% |
Q3 2020 | $2,289,000 | -1.2% | 124,804 | -3.8% | 0.00% | 0.0% |
Q2 2020 | $2,316,000 | +7.4% | 129,693 | -2.5% | 0.00% | 0.0% |
Q1 2020 | $2,157,000 | +7.0% | 132,999 | +18.8% | 0.00% | 0.0% |
Q4 2019 | $2,016,000 | +477.7% | 111,949 | +550.3% | 0.00% | – |
Q3 2019 | $349,000 | – | 17,216 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |